Home / Posts Tagged "Medical Device company"

Quarterly and FY 25 Consolidated Revenue growth of 17% and 21% respectively on a YoY basis FY 25 Consolidated EBITDA growth of 27% on a YoY basis, Q4 Core EBITDA margin 27.1% Consolidated Quarterly and yearly PAT Growth of 34% and 31% respectively on a YoY basis;

READ MORE